Partner Scott Memmott and associates Jacob Harper and Jonathan York wrote an article for Law360, explaining that although the US Department of Justice's (DOJ’s) COVID-19 fraud enforcement has so far focused on individuals and entities blatantly abusing pandemic assistance funds, health care and life sciences companies should assess their compliance programs as the DOJ will likely turn to larger-dollar activity at the organization level soon.